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We  evaluated a personal protective equipment re-
moval protocol designed to minimize wearer contamination 
with pathogens. Following this protocol often resulted in vi-
rus transfer to hands and clothing. An altered protocol or 
other measures are needed to prevent healthcare worker 
contamination.
C
aring for patients with communicable diseases places 
healthcare workers (HCWs) at risk. Infected HCWs 
may not only incur serious illness or death themselves but 
may spread infection to others. Methods to prevent HCW 
infections include vaccination (1), hand hygiene (2), and 
isolation of patients with communicable diseases (3).
A key aspect of patient isolation is proper use of per-
sonal protective equipment (PPE) to protect HCWs from 
pathogen exposure during patient care. PPE includes use of 
barriers (gowns, gloves, eye shields) and respiratory pro-
tection (masks, respirators) to protect mucous membranes, 
airways, skin, and clothing from contact with infectious 
agents (3). The importance of PPE was underscored in 
the recent outbreak of severe acute respiratory syndrome 
(SARS). HCWs accounted for ≈20% of cases (4); failure to 
properly use PPE was a risk factor for HCW infection (5).
This outbreak raised concern that HCWs could con-
taminate their skin or clothes with pathogens during PPE 
removal, resulting in accidental self-inoculation and virus 
spread to patients, other HCWs, or fomites. The Centers 
for Disease Control and Prevention (CDC) addressed this 
concern by designing a protocol to minimize contami-
nation to the wearer during PPE removal (Figure 1) (6). 
However, the effectiveness of this protocol in preventing 
self-contamination has not been validated. To determine if 
removing PPE according to the CDC protocol prevents vi-
ral contamination of the wearer, a human challenge study 
was undertaken using a nonpathogenic virus.
The Study 
PPE (gowns, gloves, respirators, and goggles) donned 
by volunteers was contaminated with bacteriophage MS2, 
a nonenveloped, nonpathogenic RNA virus suspended 
in 0.01 mol/L phosphate-buffered saline and GloGerm 
(GloGerm, Moab, UT, USA), synthetic beads that ﬂ  uo-
resce under UV light (for visual tracking of virus). Sites 
of contamination were as follows: front shoulder of gown, 
back shoulder of gown, right side of N95 respirator, upper 
right front of goggles, and palm of dominant hand. Each 
site was contaminated with a total of 104 PFU of MS2 in 
5 drops of 5 μL each. Participants performed a healthcare 
task (measuring blood pressure on a mannequin) and then 
removed PPE according to CDC protocol. Hands, items 
of PPE, and scrubs worn underneath were sampled for vi-
rus. Hands were sampled by using the glove juice method 
(7). Each hand was placed inside a bag containing 75 mL 
stripping solution (0.4 g KH2PO4, 10.1 g Na2HPO4, 1.0 
mL Triton-X/L) and massaged for 60 seconds to cover all 
hand surfaces with solution. PPE items were immersed in 
1.5% beef extract, pH 7.5, and agitated on a shaker for 20 
minutes. Eluent from hands and PPE was assayed by the 
most probable number (MPN) enrichment infectivity assay 
(8). To prevent cross-contamination, samples from only 1 
volunteer were processed at a time, and individual eluent 
samples were processed separately in a biological safety 
cabinet, with decontamination in between.
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Figure 1. Centers for Disease Control and Prevention protocol for 
removing healthcare worker PPE.When an a priori value of 25% was used for the 95% 
upper conﬁ  dence limit when p (transfer) = 0, the sample 
size was N = 10. Protocols were approved by the University 
of North Carolina (UNC) Biomedical Institutional Review 
Board, and written informed consent was obtained. En-
rolled participants met the following inclusion criteria: >18 
years of age, nonpregnant, nonallergic to latex, no active 
skin disorders, and medical evaluation approval for N95 
respirator ﬁ  t testing and use (9). Experiments took place in 
a patient care room in the UNC Hospitals’ General Clinical 
Research Center. The experimental protocol is shown in 
Figure 2. Participants were shown the poster distributed by 
CDC (Figure 1) and given an opportunity to read it and ask 
questions. The poster was placed in front of the participants 
for reference while they donned and removed PPE.
Ten study participants were enrolled in this study: 9 
women and 1 man. Nine participants were right-handed, 
and 1 was left-handed. Transfer of virus to both hands, the 
initially uncontaminated glove on the nondominant hand, 
and the scrub shirt and pants worn underneath the PPE was 
observed in most volunteers (Table). Because of the dif-
ﬁ  culty of sampling large facial areas, visible ﬂ  uorescent 
tracer was used as the criterion to determine whether the 
face would be sampled. No tracer was observed on the fa-
cial areas of any volunteer. The ﬂ  uorescent tracer was not 
a consistent indicator of virus contamination; virus was re-
covered both from sites where tracer was visible and where 
it was not detected.
The amount of virus recovered was 1–3 log10 MPN for 
hands and 1–4 log10 MPN for scrubs. The mean amount of 
virus recovered from the right hand (the dominant hand of 
90% of volunteers) was greater than that recovered from 
the left hand. While removal of gloves and gowns required 
2 hands, mask and goggle removal was one-handed, which 
could have resulted in larger quantities of virus being trans-
ferred to the dominant hand during removal. In the single 
left-handed study participant, recovery of virus was greater 
from the left hand than the right (1.82 log10 vs. 0.98 log10 
MPN). The mean amount of virus recovered from scrub 
shirts was signiﬁ  cantly greater than that recovered from 
pants (p = 0.01), possibly because of contact with hands 
when the gown is pulled away from the shoulder during 
removal.
Conclusions
PPE is vital for protecting HCWs from occupationally 
acquired infection during patient care, particularly from 
droplet- or airborne-transmitted diseases. However, remov-
ing PPE after patient care without contaminating skin or 
clothes is important. Although PPE is usually worn only 
for short periods, viruses such as inﬂ  uenza (10) and SARS 
coronavirus (11) can survive for hours on surfaces, and 
viral infection can be spread by surface-to-hand (12) and 
hand-to-hand contact (13).
Developing and validating an algorithm for removing 
PPE that prevents contamination of the skin and clothes 
of HCWs are key to interrupting nosocomial transmission 
of infectious agents. These experiments demonstrate that 
the current CDC algorithm is insufﬁ  cient to protect HCWs 
from contamination during PPE removal. However, options 
that might prevent such contamination do exist, including 
double gloving, use of surgical protocols for PPE removal, 
and PPE impregnated with an antimicrobial agent.
A double-glove removal sequence would begin with 
removal of the outer glove, followed by removal of gog-
gles or face shield, gown, and respirator/mask, and ﬁ  n-
ishing with removal of the inner glove followed by hand 
DISPATCHES
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Figure 2. Protocol for human challenge experiments. PPE, personal 
protective equipment; CDC, Centers for Disease Control and 
Prevention.
Table. Frequency and levels of viral contamination of selected sites, virus transfer study, 2007* 
Site
% Volunteers who transferred 
virus to site (N = 10) 
Mean viral titer recovered from site 
(log10 MPN) 
% Contaminated sites with 
visible tracer (N = 10) 
Nondominant glove  80 2.2 10
Right hand (skin)  90 2.4 20
Left hand (skin)  70 1.8 0
Scrub shirt  100 3.2 10
Scrub pants  75† 2.1 0
Face 0 – –
*MPN, most probable number; –, not measured. 
†N = 8. 
PPE use
Perform simulated healthcare task 
(use blood pressure cuff to take the blood 
pressure of a mannequin on an 
examination bed in the room; count the 
pulse at the wrist)
Remove PPE (with CDC poster visible for 
reference at all times)
Place virus/tracer on PPE
Don PPE (contact isolation gown, N95 
respirator, goggles, gloves)
Put on scrub shirt and pants
Undergo fit testing and instruction in how 
to put on and fit check N95 respirator
Participant’s face and hands examined 
under UV light for the presence of tracer
Participant’s hands sampled using glove 
juice method
Participant’s hands cleaned with 
antimicrobial soap and 70% ethanol
Scrubs and PPE collected and 
examined under UV light for presence of 
tracer
Scrubs and PPE placed in sterile eluent 
and transported to laboratory for 
analysis
Sampling
Participant removes scrubs and is 
showered to remove any virus/tracerVirus Transfer from PPE
hygiene; handling of PPE with ungloved hands is avoided. 
Borrowing PPE protocols from surgery, in which the ends 
of gown sleeves are tucked underneath gloves during wear, 
might also reduce contamination. When the HCW is ﬁ  n-
ished, goggles and respirator are removed ﬁ  rst, and gown 
and gloves are then removed together by peeling off both at 
the same time, again avoiding handling PPE with ungloved 
hands. Finally, the use of PPE impregnated with antimicro-
bial agents might also reduce or eliminate contamination of 
skin and clothes.
This study also indicates the need for continued em-
phasis on hand hygiene. A barrier to improving hand hy-
giene compliance rates is the belief that gloves make hand 
hygiene unnecessary (14). This is contradicted by our study 
and others showing that organisms can spread from gloves 
to hands after glove removal (15). Even if double gloving is 
incorporated into protocols for PPE use, it is not a substitute 
for proper hand hygiene. Before these or other candidate 
methods are introduced into clinical practice, their impact 
on the safety of HCWs should be validated by testing with 
methods such as we have described.
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